Cat Allergy in Humans Market

Cat Allergy in Humans Market Outlook 2031

• The global cat allergy in humans market was valued at US$ 4.2 Bn in 2021
• The global market is projected to grow at a CAGR of 6.3% from 2022 to 2031
• The global cat allergy in humans market is anticipated to exceed US$ 7.8 Bn by 2031

Overview of Cat Allergy in Humans Market

When people are exposed to various pets, such as dogs and cats, they develop a variety of allergies. The most common types of allergies are runny nose, sneezing, nasal congestion, itchy eyes, as well as skin rash. Allergies to cat is a human allergic reaction to allergens produced by cats. Cat allergens of the most common types are Fel d1 (secreted by the cat’s sebaceous glands) and Fel d4 (found in the cat’s saliva). pet allergy affects nearly 25% of allergic patients due to Fel d1 and Fel d4 proteins. Cat allergens, particularly Fel d1, are abundant in the form of dander and are thought to be a major cause of allergic asthma around the world. The primary treatment for allergic patients is to avoid cats. Certain allergy Treatment and allergy shots, on the other hand, can help control the symptoms of cat allergies.

Request a sample to get extensive insights into the Cat Allergy in Humans Market

Rise in Adoption of Cats as Pets to Drive Global Market

Pet humanization is becoming a globally accepted term in the pet industry, as an increasing number of pet owners want to provide their pets with human-like products or experiences. For instance, according to Pet data, in 2018, the adoption rate for dogs in China was 11.8% dogs and 19.9% for cats.

According to data from Allergy, Asthma & Immunology Research, in 2018, allergies to dogs and cats affected 10% to 20% of the global population with allergic rhino conjunctivitis and allergic asthma. Rising prevalence of various types of pet allergies, increasing investment by manufacturers in the development of novel Cat allergy therapeutics, and growing importance of self-medication are primary factors driving the market.

Key Players Proactively Working In the Cat Allergy in Humans Market

Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co. Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, Stallergenes Greer, Other prominent players

Request a custom report on Cat Allergy in Humans Market